502
Views
1
CrossRef citations to date
0
Altmetric
Reviews

T cell receptor revision and immune repertoire changes in autoimmune diseases

, , , &
Pages 517-533 | Received 06 Jan 2021, Accepted 10 May 2021, Published online: 09 Jul 2021
 

Abstract

Autoimmune disease (AID) is a condition in which the immune system breaks down and starts to attack the body. Some common AIDs include systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes mellitus and so forth. The changes in T-cell receptor (TCR) repertoire have been found in several autoimmune diseases, and may be responsible for the breakdown of peripheral immune tolerance. In this review, we discussed the processes of TCR revision in peripheral immune environment, the changes in TCR repertoire that occurred in various AIDs, and the specifically expanded T cell clones. We hope our discussion can provide insights for the future studies, helping with the discovery of disease biomarkers and expanding the strategies of immune-targeted therapy.

    Highlights

  • Restricted TCR repertoire and biased TCR-usage are found in a variety of AIDs.

  • TCR repertoire shows tissue specificity in a variety of AID diseases.

  • The relationship between TCR repertoire diversity and disease activity is still controversial in AIDs.

  • Dominant TCR clonotypes may help to discover new disease biomarkers and expand the strategies of immune-targeted therapy.

Acknowledgment

We thank all the authors of those included studies for their useful results.

Declaration of interest

The authors declare that they have no conflict of interest.

Additional information

Funding

The present work was supported by grants from the Science and Technology Development Fund of Pudong New District Minsheng Scientific Research (Medical and Health) Project (No. PKJ2018-Y39), the National Natural Science Foundation of China (No. 81800696, 81873636), Talent Youth Cultivation Plan of Pudong New District (No. PWRq2020-11), Shanghai Medical Key Specialty (No. ZK2019C09) and “Top-100 Talent Cultivation Plan” of Shanghai University of Medicine and Health Sciences (No. B3-0200-20-311008-30).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.